ProKidney Corp. (PROK)
NASDAQ: PROK
· Real-Time Price · USD
2.33
0.03 (1.30%)
At close: Sep 05, 2025, 10:08 AM
1.30% (1D)
| Bid | 2.32 |
| Market Cap | 695.17M |
| Revenue (ttm) | 527K |
| Net Income (ttm) | -72.47M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -4.31 |
| Forward PE | -4.21 |
| Analyst | Strong Buy |
| Ask | 2.33 |
| Volume | 472,779 |
| Avg. Volume (20D) | 13,625,348 |
| Open | 2.31 |
| Previous Close | 2.30 |
| Day's Range | 2.31 - 2.44 |
| 52-Week Range | 0.46 - 7.13 |
| Beta | 1.81 |
About PROK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PROK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PROK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-8.67%
PROK stock has given up its prior gain. ProKidney ...
Unlock content with
Pro Subscription
1 month ago
-8.67%
ProKidney shares are trading higher after the company announced it is aligned with the FDA regarding the accelerated approval and pathway for Rilparencel.
1 month ago · https://247wallst.com
Live Nasdaq Composite: Markets Attempt Gains on Renewed Trade Deal BetsLive Updates Live Coverage Has Ended X Executive Shakeup 1:06 pm by Gerelyn Terzo Uncertainty has gripped yet another one of Elon Musk’s companies after X CEO Linda Yaccarino revealed she would ...
